RECRUITING

Affirmative Psychotherapy for Sexual Minority Women's Mental and Behavioral Health

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this 2-arm randomized controlled trial is to assess the efficacy of a 10-session lesbian, gay, bisexual, transgender, and queer (LGBTQ)-affirmative cognitive-behavioral psychotherapy (CBT) delivered via telehealth in a large sample of sexual minority women (SMW) in New York, New Jersey and Pennsylvania. The investigators will assess whether the EQuIP (Empowering Queer Identities in Psychotherapy) treatment demonstrates significant reductions in heavy drinking (HD) and mental health symptoms (e.g., depression) compared to LGBTQ-affirmative treatment-as-usual.

Official Title

A Unified Protocol to Address Sexual Minority Women's Minority Stress, Mental Health and Hazardous Drinking

Quick Facts

Study Start:2023-02-01
Study Completion:2027-06-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05509166

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. be 18 years of age or older
  2. 2. be fluent in English
  3. 3. self-identify as lesbian, bisexual, queer, pansexual, or other non-heterosexual identity
  1. 1. report current mental health treatment ≥1 day/mo
  2. 2. report having received any CBT in the past 3 months
  3. 3. report current alcohol or drug abuse treatment, except mutual self-help (e.g., Alcoholics Anonymous)
  4. 4. need alcohol detoxification indicated by ≥9 on Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar)
  5. 5. exhibit active psychosis or active mania, as assessed by the Structured Clinical Interviews for DSM-5 Disorders (SCID) Psych Screen
  6. 6. exhibit active suicidality or active homicidality, as assessed by the SCID-Psych Screen
  7. 7. be currently legally mandated to attend treatment
  8. 8. demonstrate gross cognitive impairment, as assessed with the Telephone Interview for Cognitive Status

Contacts and Locations

Study Contact

John E Pachankis, PhD
CONTACT
646-429-9407
John.Pachankis@yale.edu
Danielle M Chiaramonte, PhD
CONTACT
708-334-8331
Danielle.Chiaramonte@yale.edu

Principal Investigator

John E Pachankis, PhD
PRINCIPAL_INVESTIGATOR
Yale University
Tonda Hughes, PhD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Yale LGBTQ Mental Health Initiative with the Yale School of Public Office
New York, New York, 10001
United States

Collaborators and Investigators

Sponsor: Yale University

  • John E Pachankis, PhD, PRINCIPAL_INVESTIGATOR, Yale University
  • Tonda Hughes, PhD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-01
Study Completion Date2027-06-01

Study Record Updates

Study Start Date2023-02-01
Study Completion Date2027-06-01

Terms related to this study

Keywords Provided by Researchers

  • LGBTQ
  • Cognitive Behavioral Therapy

Additional Relevant MeSH Terms

  • Heavy Drinking
  • Mental Health Issue